0001144204-16-084414.txt : 20160226 0001144204-16-084414.hdr.sgml : 20160226 20160226060339 ACCESSION NUMBER: 0001144204-16-084414 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160222 FILED AS OF DATE: 20160226 DATE AS OF CHANGE: 20160226 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SCICLONE PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000880771 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943116852 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 950 TOWER LANE STREET 2: SUITE 900 CITY: FOSTER CITY STATE: CA ZIP: 94404-2125 BUSINESS PHONE: 650-358-3456 MAIL ADDRESS: STREET 1: 950 TOWER LANE STREET 2: SUITE 900 CITY: FOSTER CITY STATE: CA ZIP: 94404-2125 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GL CAPITAL MANAGEMENT GP Ltd CENTRAL INDEX KEY: 0001667828 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19825 FILM NUMBER: 161457822 BUSINESS ADDRESS: STREET 1: UNIT 3001, CHINA WORLD TOWER 2 STREET 2: NO. 1 JIAN GUO MEN WAI AVENUE CITY: BEIJING STATE: F4 ZIP: 100004 BUSINESS PHONE: 861059611212 MAIL ADDRESS: STREET 1: UNIT 3001, CHINA WORLD TOWER 2 STREET 2: NO. 1 JIAN GUO MEN WAI AVENUE CITY: BEIJING STATE: F4 ZIP: 100004 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GL Partners Capital Management Ltd CENTRAL INDEX KEY: 0001562291 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19825 FILM NUMBER: 161457823 BUSINESS ADDRESS: STREET 1: A-31F,GLOBAL TRADE,MANSION 9,GUANGHUA RD CITY: BEIJING STATE: F4 ZIP: 100020 BUSINESS PHONE: 86-010-5961 1212 MAIL ADDRESS: STREET 1: A-31F,GLOBAL TRADE,MANSION 9,GUANGHUA RD CITY: BEIJING STATE: F4 ZIP: 100020 3 1 v432599_form3.xml OWNERSHIP DOCUMENT X0206 3 2016-02-22 0 0000880771 SCICLONE PHARMACEUTICALS INC SCLN 0001562291 GL Partners Capital Management Ltd UNIT 3001, CHINA WORLD TOWER 2, NO. 1 JIAN GUO MEN WAI AVENUE BEIJING F4 100004 CHINA 0 0 1 0 0001667828 GL CAPITAL MANAGEMENT GP Ltd UNIT 3001, CHINA WORLD TOWER 2 NO. 1 JIAN GUO MEN WAI AVENUE BEIJING F4 100004 CHINA 0 0 1 0 Common Stock, par value $0.001 per share 4750116 I See Footnote 4,750,116 shares of the common stock of Sciclone Pharmaceutical, Inc. (the "Company") are owned by GL Trade Investment Limited ("GL Trade"). GL China Opportunities Fund L.P. ("GL Fund") owns 100% of the voting interests in GL Trade. GL Capital Management GP L.P. ("GL Capital") is the general partner of GL Fund. GL Capital Management GP Limited ("GL Management") is the general partner of GL Capital. GL Partners Capital Management Limited owns 51% of the voting interests in GL Management. On the basis of the foregoing relationship, each of GL Trade, GL Fund, GL Capital, GL Management and GL Partners Capital Management Limited may be deemed a beneficial owner of the Company's common stock owned by GL Trade, but each such person disclaims beneficial ownership of such shares of common stock except to the extent of such person's pecuniary interest therein, if any. GL Management may be considered a member of a group beneficially owning more than 10% of the Company's common stock for purposes of Rule 16a-1(a)(1) under the Securities Exchange Act of 1934. Neither the filing of this Form 3 nor any of its contents shall be deemed to constitute an admission by GL Management, GL Partners Capital Management Limited, or any other person that any such group exists and each of GL Management and GL Partners Capital Management Limited expressly disclaims the existence of such a group. GL Partners Capital Management Limited by /s/ Li Zhenfu, Director 2016-02-26 GL Capital Management GP Limited by /s/ Li Zhenfu, Director 2016-02-26